[1] Ibáñez-Martínez E, Ruiz-Gaitán A, Pemán-García J. Update on the diagnosis of invasive fungal infection[J]. Rev Esp Quimioter, 2017,30(Suppl 1):16-21. [2] Xiao M,Sun ZY,Kang M, et al. Five-year national surveillance of invasive candidiasis:Species distribution and azole susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study[J]. J Clin Microbiol, 2018. 56(7):e00577-18. [3] Lockhart SR, Lqbal N, Cleveland AA, et al.Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011[J]. J Clin Microbiol, 2012,50(11):3435-3442. [4] Li F, Wu L, Cao B, et al, Surveillance of the prevalence, antibiotic susceptibility, and genotypic characterization of invasive candidiasis in a teaching hospital in China between 2006 to 2011[J]. BMC Infect Dis, 2013,13:353. [5] Pereira GH, Müller PR, Szeszs MW, et al. Five-year evaluation of bloodstream yeast infections in a tertiary hospital:the predominance of non-C. albicans Candida species[J]. Med Mycol, 2010,48(6):839-842. [6] Vincent JL, Rello J, Marshall J,et al. International study of the prevalence and outcomes of infection in intensive care units[J].JAMA,2009,302(21):2323-2329. [7] Zhang L, Xiao M, Watts MR, et al. Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy[J]. BMC Infect Dis, 2015, 15:340. [8] Andes D, Forrest A, Lepak A, et al. Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo:fluconazole and Candida albicans[J]. Antimicrob Agents Chemother, 2006. 50(7):2374-2383. [9] Barchiesi F,Calabrese D,Sanglard D, et al. Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750[J]. Antimicrob Agents Chemother, 2000, 44(6):1578-1584. [10] Wingard JR, Merz WG, Rinaldi MG, et al. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole[J]. N Engl J Med, 1991,325(18):1274-1277. [11] Wingard JR, Merz WG, Rinaldi MG,et al. Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients[J]. Antimicrob Agents Chemother, 1993, 37(9):1847-1849. [12] Perlin DS. Resistance to echinocandin-class antifungal drugs[J]. Drug Resist Updat, 2007,10(3):121-130. [13] Franz R, Kelly SL, Lamb DC, et al. Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains[J]. Antimicrob Agents Chemother, 1998,42(12):3065-3072. |